Mortality in cold agglutinin disease shows seasonal pattern

Dennis Lund Hansen; Sören Möller; Sigbjørn Berentsen; Henrik Frederiksen

doi:10.1111/trf.16894

Mortality in cold agglutinin disease shows seasonal pattern

Dennis Lund Hansen^*, Sören Möller, Sigbjørn Berentsen, Henrik Frederiksen

^*Kontaktforfatter

Haugesund sjukehus - Helse Fonna

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Formidling

11 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Transfusion
Vol/bind	62
Udgave nummer	7
Sider (fra-til)	1460-1461
ISSN	0041-1132
DOI	https://doi.org/10.1111/trf.16894
Status	Udgivet - jul. 2022

Bibliografisk note

Funding Information:
The authors have disclosed no conflicts of interest with this study. Outside of the study DLH: research grants from Alexion and Novartis, conference fee from EUSA Pharma. SM: None. HF: project grants from Novartis, Alexion, Sanofi, and Gilead for research unrelated to this study, and honoraria from Sanofi and Alexion for lectures on thrombotic microangiopathies. SB: Advisory board/consultancy honoraria from Annexon, Apellis, Bioverativ, Momenta Pharmaceuticals, Sanofi‐Genzyme, and SOBI: lecture honoraria from Apellis, Janssen‐Cilag, and Sanofi‐Genzyme.

Dokumenter og links

10.1111/trf.16894Licens: CC BY-NC

Open Access VersionForlagets udgivne version, 205 KBLicens: CC BY-NC

Citationsformater

@article{4019f5a5fdb7446ea627020d0e1008a6,

title = "Mortality in cold agglutinin disease shows seasonal pattern",

author = "Hansen, {Dennis Lund} and S{\"o}ren M{\"o}ller and Sigbj{\o}rn Berentsen and Henrik Frederiksen",

note = "Funding Information: The authors have disclosed no conflicts of interest with this study. Outside of the study DLH: research grants from Alexion and Novartis, conference fee from EUSA Pharma. SM: None. HF: project grants from Novartis, Alexion, Sanofi, and Gilead for research unrelated to this study, and honoraria from Sanofi and Alexion for lectures on thrombotic microangiopathies. SB: Advisory board/consultancy honoraria from Annexon, Apellis, Bioverativ, Momenta Pharmaceuticals, Sanofi‐Genzyme, and SOBI: lecture honoraria from Apellis, Janssen‐Cilag, and Sanofi‐Genzyme.",

year = "2022",

month = jul,

doi = "10.1111/trf.16894",

language = "English",

volume = "62",

pages = "1460--1461",

journal = "Transfusion",

issn = "0041-1132",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - Mortality in cold agglutinin disease shows seasonal pattern

AU - Hansen, Dennis Lund

AU - Möller, Sören

AU - Berentsen, Sigbjørn

AU - Frederiksen, Henrik

N1 - Funding Information: The authors have disclosed no conflicts of interest with this study. Outside of the study DLH: research grants from Alexion and Novartis, conference fee from EUSA Pharma. SM: None. HF: project grants from Novartis, Alexion, Sanofi, and Gilead for research unrelated to this study, and honoraria from Sanofi and Alexion for lectures on thrombotic microangiopathies. SB: Advisory board/consultancy honoraria from Annexon, Apellis, Bioverativ, Momenta Pharmaceuticals, Sanofi‐Genzyme, and SOBI: lecture honoraria from Apellis, Janssen‐Cilag, and Sanofi‐Genzyme.

PY - 2022/7

Y1 - 2022/7

U2 - 10.1111/trf.16894

DO - 10.1111/trf.16894

M3 - Journal article

C2 - 35531960

AN - SCOPUS:85129554417

SN - 0041-1132

VL - 62

SP - 1460

EP - 1461

JO - Transfusion

JF - Transfusion

IS - 7

ER -